Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 May 2003

Determination of intracellular NAD+ levels to study biological damage induced by pesticides

M. Faraone-Mennella, M. Malanga, A. Petrella, A. Ferone, C. Bufi, B. Farina

Med Sci Monit 2003; 9(1): 23-0 :: ID: 15073

Abstract

Exposure to environmental pollutants has been identified as one of the major causes of tumors in humans. Epidemiological data showed an increase of cancer incidence among farmers using pesticides. Different studies have shown that many of the compounds used in agriculture are able to interact with DNA, either directly or after metabolic activation, as well as other research evidenced that DNA structural alteration plays a primary role in neoplastic transformation, with implications of the poly(ADPribosyl)ation reaction.Increased intracellular levels of poly(ADPribose) and concomitant reduction of NAD+ content are typically found in cells undergoing genotoxic stress. Overactivation of PARP causes an extensive decrease of cellular NAD+ and ATP depletion, and induces cell necrosis.In our study, cellular NAD+ levels have been tested to define a new approach to evaluate the biological damage in a healthy population of farmers (in particular floriculturists) exposed routinely to the use of pesticides.Lymphocytes were prepared from peripheral blood of 100 subjects, either exposed or not exposed (controls) to pesticides and were used to monitor NAD+ levels according to classic procedures [1,2]. In parallel, aliquots of blood samples were subjected to conventional laboratory analyses to assess the health status at the time of recruitment. All the subjects answered also a questionnaire to collect individual and familiar anamnestic data.Here we present preliminary results obtained from this study, comparing the biochemical ones with epidemiological data. References: 1.Bernofsky C, Swan M: Anal Biochem, 1973; 53: 452 2.Jacobson EL, Jacobson MK: Meth Enzymol, 1997; 280: 221

Keywords: NAD+, Pesticides, farmer, Necrosis

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

26 Feb 2024 : Clinical Research  

Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...

Med Sci Monit In Press; DOI: 10.12659/MSM.942509  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750